Abstract
Background: Natural aristolochia alkaloids have attracted the attention of both chemists and biologists from the stand point of their structural and pharmacological aspects. Many of the compounds isolated in this group are potent tumor inhibitors. These are divided into nitrophenanthrinic acid, phenanthrene lactams and isoquinoline alkaloids. A number of structure-activity studies have been performed on aristolochia alkaloids. Of particular interest is the molecule with the β-D-glucoside moiety that has similarity to the clinical anticancer agent daunomycin.
Objective: The anticancer activity of aristololactam-β-D-glucoside has been thought to be due to its DNA and RNA binding activities among other actions. In this article we focus on the physicochemical property of this alkaloid and the structural and functional aspects of its binding to different nucleic acid and protein structures.
Methods: This review highlights a large number of biophysical studies employing various analytical techniques like absorbance, fluorescence, circular dichroism, thermal melting, viscosity, IR study, isothermal calorimetry and differential scanning calorimetry.
Result: The detailed binding mechanism in terms of the structural and thermodynamic aspects at the molecular level has been discussed.
Conclusion: This review enables to assess the high potential of developing aristololactam-β-Dglucoside and related alkaloids as therapeutic agents.
Keywords: Aristolochia indica, aristololactam-β-D-glucoside, nucleic acids, protein, spectroscopy, calorimetry, therapeutic potential.
Graphical Abstract
Mini-Reviews in Medicinal Chemistry
Title:Natural Aristolochia Alkaloid Aristololactam-β-D-glucoside: Interaction with Biomacromolecules and Correlation to the Biological Perspectives
Volume: 18 Issue: 12
Author(s): Abhi Das and Gopinatha Suresh Kumar*
Affiliation:
- Biophysical Chemistry Laboratory, Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032,India
Keywords: Aristolochia indica, aristololactam-β-D-glucoside, nucleic acids, protein, spectroscopy, calorimetry, therapeutic potential.
Abstract: Background: Natural aristolochia alkaloids have attracted the attention of both chemists and biologists from the stand point of their structural and pharmacological aspects. Many of the compounds isolated in this group are potent tumor inhibitors. These are divided into nitrophenanthrinic acid, phenanthrene lactams and isoquinoline alkaloids. A number of structure-activity studies have been performed on aristolochia alkaloids. Of particular interest is the molecule with the β-D-glucoside moiety that has similarity to the clinical anticancer agent daunomycin.
Objective: The anticancer activity of aristololactam-β-D-glucoside has been thought to be due to its DNA and RNA binding activities among other actions. In this article we focus on the physicochemical property of this alkaloid and the structural and functional aspects of its binding to different nucleic acid and protein structures.
Methods: This review highlights a large number of biophysical studies employing various analytical techniques like absorbance, fluorescence, circular dichroism, thermal melting, viscosity, IR study, isothermal calorimetry and differential scanning calorimetry.
Result: The detailed binding mechanism in terms of the structural and thermodynamic aspects at the molecular level has been discussed.
Conclusion: This review enables to assess the high potential of developing aristololactam-β-Dglucoside and related alkaloids as therapeutic agents.
Export Options
About this article
Cite this article as:
Das Abhi and Kumar Suresh Gopinatha *, Natural Aristolochia Alkaloid Aristololactam-β-D-glucoside: Interaction with Biomacromolecules and Correlation to the Biological Perspectives, Mini-Reviews in Medicinal Chemistry 2018; 18 (12) . https://dx.doi.org/10.2174/1389557518666180222170050
DOI https://dx.doi.org/10.2174/1389557518666180222170050 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Combination of Anti-EGFR Drugs and Other Molecular Targeted Agents as Anti-Cancer Strategy
Current Cancer Therapy Reviews Reactions of Nitrogen Derivatives of Carbonyl Compounds with Phenyliodoso Diacetate in Organic Synthesis
Current Organic Synthesis Molecular Insight and Binding Pattern Analysis of Shikonin as a Potential VEGFR-2 Inhibitor
Current Enzyme Inhibition The Role of Endogenous H2S in Cardiovascular Physiology
Current Pharmaceutical Biotechnology Vascular Arginase and Hypertension
Current Hypertension Reviews Aldose Reductase Inhibitors and Nanodelivery of Diabetic Therapeutics
Mini-Reviews in Medicinal Chemistry Current Advancements in Aβ Luminescent Probes and Inhibitors of Aβ Aggregation
Current Alzheimer Research Antiplatelet and Antileukocyte Effects of Cardiovascular,Immunomodulatory and Chemotherapeutic Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Medicinal Chemistry of Potassium Channel Modulators: An Update of Recent Progress (2011-2017)
Current Medicinal Chemistry The Role of the Methoxyphenol Apocynin, a Vascular NADPH Oxidase Inhibitor, as a Chemopreventative Agent in the Potential Treatment of Cardiovascular Diseases
Current Vascular Pharmacology Cellular Signaling in Cartilage Tissue Engineering
Current Signal Transduction Therapy Vasopressin in Liver Disease – Should We Turn On or Off?
Current Clinical Pharmacology Community-Acquired Pneumonia in Children
Recent Patents on Inflammation & Allergy Drug Discovery Innate Immunity in Lophotrochozoans: The Annelids
Current Pharmaceutical Design Prevention of Allergic Disease Development and Symptoms by Food Factors
Current Pharmaceutical Design Extracellular Signals for Guiding Mesenchymal Stem Cells Osteogenic Fate
Current Stem Cell Research & Therapy Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry
Current Neuropharmacology From Peptides to Small Molecules: An Intriguing but Intricated Way to New Drugs
Current Medicinal Chemistry Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts
Current Radiopharmaceuticals The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML)
Current Signal Transduction Therapy